CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Pricing Analysis
3.8.Value Chain Analysis
3.9.Key Regulation Analysis
CHAPTER 4: NATIVE COLLAGEN MARKET, BY SOURCE
4.1 Overview
4.1.1 Market size and forecast
4.2 Bovine
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Porcine
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Poultry
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Marine
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: NATIVE COLLAGEN MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Healthcare and Pharmaceuticals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Healthcare and Pharmaceuticals Native Collagen Market by End Use
5.2.4.1 Bone and Joint Reconstruction Market size and forecast, by region
5.2.4.2 Bone and Joint Reconstruction Market size and forecast, by country
5.2.4.3 Wound Dressing Market size and forecast, by region
5.2.4.4 Wound Dressing Market size and forecast, by country
5.2.4.5 Tissue Regeneration Market size and forecast, by region
5.2.4.6 Tissue Regeneration Market size and forecast, by country
5.2.4.7 Others Market size and forecast, by region
5.2.4.8 Others Market size and forecast, by country
5.3 Cosmetics
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NATIVE COLLAGEN MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Source
6.2.3 North America Market size and forecast, by Application
6.2.3.1 North America Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Source
6.2.4.1.2 Market size and forecast, by Application
6.2.4.1.2.1 U.S. Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Source
6.2.4.2.2 Market size and forecast, by Application
6.2.4.2.2.1 Canada Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Source
6.2.4.3.2 Market size and forecast, by Application
6.2.4.3.2.1 Mexico Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Source
6.3.3 Europe Market size and forecast, by Application
6.3.3.1 Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Source
6.3.4.1.2 Market size and forecast, by Application
6.3.4.1.2.1 Germany Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Source
6.3.4.2.2 Market size and forecast, by Application
6.3.4.2.2.1 France Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.3 Italy
6.3.4.3.1 Market size and forecast, by Source
6.3.4.3.2 Market size and forecast, by Application
6.3.4.3.2.1 Italy Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Source
6.3.4.4.2 Market size and forecast, by Application
6.3.4.4.2.1 Spain Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Source
6.3.4.5.2 Market size and forecast, by Application
6.3.4.5.2.1 Rest of Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Source
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.3.1 Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Source
6.4.4.1.2 Market size and forecast, by Application
6.4.4.1.2.1 China Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Source
6.4.4.2.2 Market size and forecast, by Application
6.4.4.2.2.1 Japan Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Source
6.4.4.3.2 Market size and forecast, by Application
6.4.4.3.2.1 India Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Source
6.4.4.4.2 Market size and forecast, by Application
6.4.4.4.2.1 South Korea Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Source
6.4.4.5.2 Market size and forecast, by Application
6.4.4.5.2.1 Rest of Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Source
6.5.3 LAMEA Market size and forecast, by Application
6.5.3.1 LAMEA Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Source
6.5.4.1.2 Market size and forecast, by Application
6.5.4.1.2.1 Latin America Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4.2 Africa
6.5.4.2.1 Market size and forecast, by Source
6.5.4.2.2 Market size and forecast, by Application
6.5.4.2.2.1 Africa Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4.3 Middle East
6.5.4.3.1 Market size and forecast, by Source
6.5.4.3.2 Market size and forecast, by Application
6.5.4.3.2.1 Middle East Healthcare and Pharmaceuticals Native Collagen Market by End Use
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Creative Enzymes
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Symatese
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Vetoquinol S.A.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 REPROCELL USA Inc.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Aviva Systems Biology Corporation
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 RayBiotech, Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Cosmo Bio
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Bioiberica S.A.U
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Rockland Immunochemicals Inc.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
8.11 Beyond Biopharma Co., Ltd.
8.11.1 Company overview
8.11.2 Company snapshot
8.11.3 Operating business segments
8.11.4 Product portfolio
8.11.5 Business performance
8.11.6 Key strategic moves and developments
8.12 TSI GROUP
8.12.1 Company overview
8.12.2 Company snapshot
8.12.3 Operating business segments
8.12.4 Product portfolio
8.12.5 Business performance
8.12.6 Key strategic moves and developments
TABLE 1. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 2. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 3. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 ($MILLION)
TABLE 4. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 (TONS)
TABLE 5. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 7. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 ($MILLION)
TABLE 8. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 (TONS)
TABLE 9. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 11. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 (TONS)
TABLE 13. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 (TONS)
TABLE 15. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 (TONS)
TABLE 17. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 19. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 21. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 23. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 25. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 (TONS)
TABLE 27. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 (TONS)
TABLE 29. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 30. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 31. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 ($MILLION)
TABLE 32. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 (TONS)
TABLE 33. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 (TONS)
TABLE 35. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 ($MILLION)
TABLE 36. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 (TONS)
TABLE 37. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 (TONS)
TABLE 39. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 ($MILLION)
TABLE 40. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 (TONS)
TABLE 41. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 (TONS)
TABLE 43. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 44. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 45. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 47. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 48. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 (TONS)
TABLE 49. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 (TONS)
TABLE 51. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 52. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 53. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 55. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 56. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 (TONS)
TABLE 57. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 58. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 59. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 61. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 62. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 63. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 65. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 66. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 67. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 69. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 70. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 71. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 72. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 73. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 75. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 76. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 77. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 78. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 79. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 81. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 82. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 83. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 84. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 85. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 87. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 88. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 89. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 90. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 91. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 92. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 93. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 95. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 96. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 97. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 98. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 99. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 101. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 102. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 103. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 104. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 105. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 107. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 108. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 109. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 110. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 111. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 112. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 113. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 114. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 115. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 116. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 117. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 119. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 120. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 121. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 122. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 123. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 125. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 126. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 127. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 128. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 129. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 130. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 131. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 133. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 134. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 135. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 136. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 137. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 138. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 139. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 140. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 141. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 142. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 143. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 144. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 145. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 146. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 147. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 148. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 149. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 150. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 151. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 152. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 153. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 154. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 155. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 156. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 157. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 158. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 159. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 160. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 161. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 162. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 163. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 164. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 165. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 166. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 167. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 168. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 169. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 170. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 171. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 172. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 173. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 174. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 175. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 176. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 177. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 178. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 179. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 180. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 181. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 182. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 183. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 184. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 185.CREATIVE ENZYMES: COMPANY SNAPSHOT
TABLE 186.CREATIVE ENZYMES: OPERATING SEGMENTS
TABLE 187.CREATIVE ENZYMES: PRODUCT PORTFOLIO
TABLE 188.CREATIVE ENZYMES: NET SALES,
TABLE 189.CREATIVE ENZYMES: KEY STRATERGIES
TABLE 190.SYMATESE: COMPANY SNAPSHOT
TABLE 191.SYMATESE: OPERATING SEGMENTS
TABLE 192.SYMATESE: PRODUCT PORTFOLIO
TABLE 193.SYMATESE: NET SALES,
TABLE 194.SYMATESE: KEY STRATERGIES
TABLE 195.VETOQUINOL S.A.: COMPANY SNAPSHOT
TABLE 196.VETOQUINOL S.A.: OPERATING SEGMENTS
TABLE 197.VETOQUINOL S.A.: PRODUCT PORTFOLIO
TABLE 198.VETOQUINOL S.A.: NET SALES,
TABLE 199.VETOQUINOL S.A.: KEY STRATERGIES
TABLE 200.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 201.BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 202.BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 203.BIO-RAD LABORATORIES, INC.: NET SALES,
TABLE 204.BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
TABLE 205.REPROCELL USA INC.: COMPANY SNAPSHOT
TABLE 206.REPROCELL USA INC.: OPERATING SEGMENTS
TABLE 207.REPROCELL USA INC.: PRODUCT PORTFOLIO
TABLE 208.REPROCELL USA INC.: NET SALES,
TABLE 209.REPROCELL USA INC.: KEY STRATERGIES
TABLE 210.AVIVA SYSTEMS BIOLOGY CORPORATION: COMPANY SNAPSHOT
TABLE 211.AVIVA SYSTEMS BIOLOGY CORPORATION: OPERATING SEGMENTS
TABLE 212.AVIVA SYSTEMS BIOLOGY CORPORATION: PRODUCT PORTFOLIO
TABLE 213.AVIVA SYSTEMS BIOLOGY CORPORATION: NET SALES,
TABLE 214.AVIVA SYSTEMS BIOLOGY CORPORATION: KEY STRATERGIES
TABLE 215.RAYBIOTECH, INC.: COMPANY SNAPSHOT
TABLE 216.RAYBIOTECH, INC.: OPERATING SEGMENTS
TABLE 217.RAYBIOTECH, INC.: PRODUCT PORTFOLIO
TABLE 218.RAYBIOTECH, INC.: NET SALES,
TABLE 219.RAYBIOTECH, INC.: KEY STRATERGIES
TABLE 220.COSMO BIO: COMPANY SNAPSHOT
TABLE 221.COSMO BIO: OPERATING SEGMENTS
TABLE 222.COSMO BIO: PRODUCT PORTFOLIO
TABLE 223.COSMO BIO: NET SALES,
TABLE 224.COSMO BIO: KEY STRATERGIES
TABLE 225.BIOIBERICA S.A.U: COMPANY SNAPSHOT
TABLE 226.BIOIBERICA S.A.U: OPERATING SEGMENTS
TABLE 227.BIOIBERICA S.A.U: PRODUCT PORTFOLIO
TABLE 228.BIOIBERICA S.A.U: NET SALES,
TABLE 229.BIOIBERICA S.A.U: KEY STRATERGIES
TABLE 230.ROCKLAND IMMUNOCHEMICALS INC.: COMPANY SNAPSHOT
TABLE 231.ROCKLAND IMMUNOCHEMICALS INC.: OPERATING SEGMENTS
TABLE 232.ROCKLAND IMMUNOCHEMICALS INC.: PRODUCT PORTFOLIO
TABLE 233.ROCKLAND IMMUNOCHEMICALS INC.: NET SALES,
TABLE 234.ROCKLAND IMMUNOCHEMICALS INC.: KEY STRATERGIES
TABLE 235.BEYOND BIOPHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 236.BEYOND BIOPHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 237.BEYOND BIOPHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 238.BEYOND BIOPHARMA CO., LTD.: NET SALES,
TABLE 239.BEYOND BIOPHARMA CO., LTD.: KEY STRATERGIES
TABLE 240.TSI GROUP: COMPANY SNAPSHOT
TABLE 241.TSI GROUP: OPERATING SEGMENTS
TABLE 242.TSI GROUP: PRODUCT PORTFOLIO
TABLE 243.TSI GROUP: NET SALES,
TABLE 244.TSI GROUP: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/